| abstract |
The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical composition including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile , including sulphated arabinogalactans; an extract of Zostera marina or Lemna minor , including apiogalacturonans; or an extract of Caulerpa racemosa , including sulphated heteroglycans. |